Moclamine (Moclobemide)

Moclobemide, the active ingredient in Moclamine, is a reversible monoamine oxidase A (MAO‑A) inhibitor presented as an oral dosage form for oral use. It treats major depressive disorder in adult patients. GNH USA supplies Moclamine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclamine is a reversible MAO‑A inhibitor indicated for depressive and anxiety disorders. - Major depressive disorder: alleviates depressive symptoms and improves mood. - Social anxiety disorder: reduces anxiety and improves social functioning.

Moclamine may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness, especially on standing. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation. - Constipation: infrequent bowel movements.

Serious or Rare Side Effects: - Hypertensive crisis: sudden severe rise in blood pressure, often triggered by tyramine‑rich foods. - Serotonin syndrome: agitation, hyperthermia, tremor when combined with serotonergic agents. - Severe liver injury: jaundice, elevated liver enzymes. - Agranulocytosis: marked reduction in white blood cells, increasing infection risk. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Psychosis: emergence of hallucinations or delusional thoughts.

Before initiating Moclamine, several safety considerations are recommended. - Hepatic assessment: evaluate liver function because the drug is metabolised hepatically. - Blood pressure monitoring: watch for hypertensive episodes, especially after high‑tyramine meals. - Dietary restrictions: avoid tyramine‑rich foods such as aged cheeses, cured meats and certain alcoholic beverages. - Serotonergic agents: do not combine with SSRIs, SNRIs, tricyclic antidepressants or linezolid without specialist supervision. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moclamine interacts with several drug classes; careful management is required.

Major Interactions (Avoid): - Other MAO inhibitors: concurrent use can cause severe hypertensive reactions. - SSRIs, SNRIs, tricyclic antidepressants: risk of serotonin syndrome. - Linezolid or methylene blue: potent MAO inhibition leading to hypertensive crisis.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase bleeding risk when combined with MAO inhibition. - Antihypertensive agents: possible additive blood pressure effects; monitor levels.